| Date | Time | Source | | | 04/25/2013 | 8:34AM | GLOBE | Trinity Biotech Announces Quarter 1 Results - EPS of 20 Cents, Premier Regulatory Approval in China and 33% Increase in Dividen
DUBLIN, Ireland, April 25, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2013. Quarter 1 Results Total revenues for Q1, 2013 were $20.3m... More...>> |
| 04/16/2013 | 5:50AM | GLOBE | Trinity Biotech plc to Announce First Quarter Fiscal Year 2013 Financial Results
DUBLIN, Ireland, April 16, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2013 on Thursday, April 25, 2013. The Company has scheduled... More...>> |
| 03/05/2013 | 7:17AM | GLOBE | Trinity Biotech Announces Results for Fiscal Year 2012
DUBLIN, Ireland, March 5, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point of care and clinical laboratory markets, today announced results for fiscal year 2012 and for the quarter ended December 31, 2012. Fiscal year 2012 Results Total... More...>> |
| 02/20/2013 | 11:00AM | GLOBE | Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2012 Financial Results
DUBLIN, Ireland, Feb. 20, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2012 on Tuesday, March 5, 2013. The Company has scheduled... More...>> |
| 10/18/2012 | 8:02AM | GLOBE | Trinity Biotech Announces Quarter 3 Financial Results
Profit After Tax increases by 13% to $4.5m EPS increases by 12% to 20.7 cents per ADR DUBLIN, Ireland, Oct. 18, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter... More...>> |
| 10/04/2012 | 5:29AM | GLOBE | Trinity Biotech plc to Announce Third Quarter Fiscal Year 2012 Financial Results
DUBLIN, Ireland, Oct. 4, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter of fiscal year 2012 on Thursday, October 18, 2012. The Company has scheduled... More...>> |
| 08/02/2012 | 8:00PM | ZACKS | Trinity Biotech - Momentum
Trinity Biotech plc (TRIB), which has delivered eight positive earnings surprises in the last ten quarters, is currently hovering around its 52-week high of $12.76 hit on July 16. ADRs of this Ireland-based diagnostic test kits and instrument company have been moving mostly upward since mid-June based on second-quarter... More...>> |
| 07/12/2012 | 7:59AM | GLOBE | Trinity Biotech Announces Quarter 2 Financial Results EPS of 20 Cents Per ADR -- an Increase of 11%
DUBLIN, Ireland, July 12, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2012. Quarter 2 Results ... More...>> |
| 07/05/2012 | 7:07AM | GLOBE | Trinity Biotech plc to Announce Second Quarter Fiscal Year 2012 Financial Results
DUBLIN, Ireland, July 5, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of fiscal year 2012 on Thursday, July 12, 2012. The Company has scheduled... More...>> |
| 06/26/2012 | 12:02PM | GLOBE | Trinity Biotech Added to Membership of Russell Global Index
DUBLIN, Ireland, June 26, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced it has been added as a member of the Russell Global Index as Russell Investments reconstituted its comprehensive... More...>> |
| 06/06/2012 | 7:00AM | GLOBE | Trinity Biotech plc Announces Details of Its Dividend and Share Buyback Program
DUBLIN, Ireland, June 6, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced additional details of its Dividend and Share Buyback Program. Annual Dividend At its most recent AGM held on 25... More...>> |
| 04/25/2012 | 7:26AM | GLOBE | Trinity Biotech Announces an Annual Dividend of 15 Cents Per ADR -- an Increase of 50%
DUBLIN, Ireland, April 25, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced a proposed dividend of 15 cents per ADR. In 2011, Trinity announced the commencement of an annual dividend... More...>> |
| 04/19/2012 | 7:36AM | GLOBE | Trinity Biotech Announces Quarter 1 Financial Results
DUBLIN, April 19, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2012. Quarter 1 Results Total revenues for Q1, 2012 were $20.0m which compares... More...>> |
| 04/10/2012 | 7:50AM | GLOBE | Trinity Biotech plc to Announce First Quarter Fiscal Year 2012 Financial Results
DUBLIN, April 10, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter of fiscal year 2012 on Thursday, April 19, 2012. The Company has scheduled... More...>> |
| 03/05/2012 | 8:32AM | GLOBE | Trinity Biotech Announces Quarter 4 Financial Results
DUBLIN, March 5, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2011. Quarter 4 Results ... More...>> |
| 03/01/2012 | 7:04AM | GLOBE | Trinity Biotech plc Announces the Acquisition of Fiomi Diagnostics AB
DUBLIN, March 1, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced its acquisition of Fiomi Diagnostics AB for $13.1m (including $3.4m of contingent payments) from the founders and... More...>> |
| 02/28/2012 | 7:00AM | GLOBE | Trinity Biotech Announces CE Marking of Rapid Test for Giardia
DUBLIN, Ireland, Feb. 28, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it had obtained CE Marking and has filed for FDA approval for its new point-of-care Uni-GoldTM Giardia... More...>> |
| 02/16/2012 | 6:48AM | GLOBE | Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2011 Financial Results
DUBLIN, Ireland, Feb. 16, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2011 on Monday, March 5, 2012. The Company has scheduled... More...>> |
| 01/04/2012 | 6:00PM | PRNUS | Trinity Biotech to Present at Sidoti & Company's Semiannual New York Micro-Cap Conference on January 9, 2012
Trinity Biotech to Present at Sidoti & Company's Semiannual New York Micro-Cap Conference on January 9, 2012 PR Newswire DUBLIN, Jan. 4, 2012 DUBLIN, Jan. 4, 2012 /PRNewswire/ -- Trinity Biotech plc (NasdaqGS: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory... More...>> |
| 12/06/2011 | 8:00AM | GLOBE | Trinity Biotech Announces FDA Approval of Premier Hb9210
DUBLIN, Ireland, Dec. 6, 2011 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has obtained FDA approval for the Premier Hb9210. The Premier instrument is a fully automated system... More...>> |
|
